Monique

Chief Strategy Officer

Hydor Horizons

Mar 2025 - Present • 1 yr 5 mos

• Architected energy-resilience and capital-allocation models for a €134M CAPEX utility-scale project of co-located solar PV + battery energy storage system projects. • Built the business model, business-model canvas, and risk-matrix analysis for 10 global jurisdictions that drove financial modeling and set investment metrics; leading to the confirmations of two pilot sites chosen in South Africa (99MWp solar + 60 MW/120MWh BESS) and Fiji (330kWp PV + 1.5MWh/500kW BESS). • Projected 10.2% baseline IRR to 17% optimized IRR on the South African asset at an LCOE of €0.097/kWh, 192,600+ tons of CO2e displaced annually across both pilots.

Founder & CEO

GEBANAH • Trabajador autónomo

Oct 2021 - Present • 4 yrs 10 mos

• Boutique strategy advisory firm directing corporate strategy and corporate development, spanning energy, fintech, sports venture studio, and healthcare AI. $80M in portfolio assets and €134M CAPEX in project value are currently under strategic oversight. • Architect of The Human-AI Agent Contract: Capital & Culture for the 2026 Leader, a self-published thought leadership piece utilizing Gebanah Strategic Alignment (GSA) reaching 4K readers and adopted by Worki. • Developer of three SaaS prototypes: AI governance & operations, sales training, and GSA diagnostic. CAPITAL, GROWTH, & ENTERPRISE STRATEGY HIGHLIGHTS: FINTECH • GTM and founder strategy for cross-border payroll and Earned Wage Access (EWA) corridors TECHNOLOGY • SaaS prototypes: AI governance & operations, sales training, GSA Diagnostic • Adopted The Human-AI Agent Contract governance model for SaaS solution • Enterprise tech solutions architect, SaaS, Data, Cloud & Infrastructure, Digital Enablement, Hardware, Security, etc, $1M sales month, launch of Google in Education, 25% YOY revenue growth GOVERNANCE & ORGANIZATIONAL STRATEGY • Led governance, financial modeling, and capital allocation for boards (70+ people), 220+ members, 50+ nonprofits, stakeholder and relationship management of 300+ businesses • 226% Revenue growth driven as nonprofit VP and board leader: $2.7M+ generated over 4-year term • University of New Haven Transformative Leadership Program Advisor improving zschool operations, education content, and selecting learning topics VENTURE & PORTFOLIO MANAGEMENT • $50M managed-fund portfolio across a venture studio ecosystem • Setting strategy for an early-stage healthcare workforce infrastructure firm leveraging agentic AI

Global Strategy | Account Manager

Galderma

Aug 2015 - May 2025 • 9 yrs 9 mos

Global Strategy and Culture Development ● Led global DEI strategy and policy development and partnership with the Global Head of Culture, Engagement and D&I, shaping initiatives across the US in Europe, and aligning them to enterprise business objectives. ● Founded and co-led the global launch of Bequal, Galderma’s LGBTQ+ ERG across six countries: (Australia, Brazil, Sweden, Switzerland, UK, US) increasing ERG engagement by 341% and reaching 3,000+ employees. ● Advised US Diversity & Inclusion Council overseeing governance and financial modeling for 3ERG’s (Women's Leadership Network, MERGE, Bequal) serving ~1,800 US employees and 15+ ERG directors. Account Manager ● Managed 100+ immunology, and dermatology accounts and lead seven product launches (including a first in class immunology therapy) and three market launches, using cross functional business plans, and market insights to identify nontraditional, revenue opportunities, and segment strategies. National Sales Trainer ● Directed cross-functional initiative with Payer Market and Professional Relations teams for a $1.1B multi-brand therapeutic dermatology BU, improving market, access, redemptions, refill campaigns, and integrated specialty pharmacy engagement. ● Co-owned cross-BU national sales and marketing strategy for the $425M Nemluvio Immunology business and $1.4B Cetaphil business unit, serving as a key field liaison and consolidating insights for the national advisory board, impacting patient, provider, and sales team marketing resources. ● Partner to senior leaders across payer access markets, HCP engagement, innovation, advocacy, sales training, and clinical operations to align regional account plans with national strategy and access programs. ● Represented flagship brands, including Nemluvio, Cetaphil, Twyneo, Epsolay, Aklief, Epiduo Forte, Soolantra, Oracea, Excipial, and Qilib.